These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9035365)

  • 1. "Hairpin" and "hammerhead" ribozymes directed towards the mumps virus nucleocapsid RNA: specific cleavage of a small synthetic RNA substrate and full-length mRNA.
    Albuquerque-Silva J; De Vos MJ; Bollen A; Houard S
    Virus Genes; 1996; 13(3):211-9. PubMed ID: 9035365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
    Denman RB
    Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribozyme-mediated decrease in mumps virus nucleocapsid mRNA level and progeny in infected vero cells.
    Albuquerque-Silva J; Milican F; Bollen A; Houard S
    Antisense Nucleic Acid Drug Dev; 1999 Jun; 9(3):279-88. PubMed ID: 10435753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
    Campbell TB; McDonald CK; Hagen M
    Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozymes that cleave an RNA sequence from human immunodeficiency virus: the effect of flanking sequence on rate.
    Goodchild J; Kohli V
    Arch Biochem Biophys; 1991 Feb; 284(2):386-91. PubMed ID: 1989522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hairpin ribozyme-mediated cleavage of the full-length beta-glucuronidase (GUS) mRNA.
    Hisamatsu S; Sonoki S; Kikuchi Y
    Biosci Biotechnol Biochem; 1995 Feb; 59(2):294-7. PubMed ID: 7766027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of hammerhead ribozymes for optimum cleavage of interleukin 6 mRNA.
    Hendrix C; Anné J; Joris B; Van Aerschot A; Herdewijn P
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):655-61. PubMed ID: 8670082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
    Sun LQ; Wang L; Gerlach WL; Symonds G
    Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and thermodynamics of intermolecular catalysis by hairpin ribozymes.
    Hegg LA; Fedor MJ
    Biochemistry; 1995 Dec; 34(48):15813-28. PubMed ID: 7495813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of viral RNA and inhibition of viral translation by hepatitis C virus RNA-specific hammerhead ribozyme in vitro.
    Ohkawa K; Yuki N; Kanazawa Y; Ueda K; Mita E; Sasaki Y; Kasahara A; Hayashi N
    J Hepatol; 1997 Jul; 27(1):78-84. PubMed ID: 9252077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A helix 1-extended hairpin ribozyme exhibits altered cleavage behavior in vitro.
    Moosbauer J; Tabler M
    Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):79-87. PubMed ID: 9149843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of highly structured viral RNA molecules by combinatorial libraries of hairpin ribozymes. The most effective ribozymes are not predicted by substrate selection rules.
    Yu Q; Pecchia DB; Kingsley SL; Heckman JE; Burke JM
    J Biol Chem; 1998 Sep; 273(36):23524-33. PubMed ID: 9722591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M; Homann M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquirement of hairpin ribozyme activity by the long substrate-binding site.
    Hisamatsu S; Sonoki S; Kikuchi Y
    Nucleic Acids Symp Ser; 1993; (29):173-4. PubMed ID: 7504243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
    Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
    Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific cleavage of natural mRNA sequences by newly designed hairpin catalytic RNAs.
    Kikuchi Y; Sasaki N
    Nucleic Acids Res; 1991 Dec; 19(24):6751-5. PubMed ID: 1762907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.
    Kuwabara T; Warashina M; Tanabe T; Tani K; Asano S; Taira K
    Nucleic Acids Res; 1997 Aug; 25(15):3074-81. PubMed ID: 9224607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of the highly conserved hairpin-loop region of HIV-1 by synthetic ribozymes.
    Shimayama T; Nishikawa S; Taira K
    Nucleic Acids Symp Ser; 1993; (29):177-8. PubMed ID: 8247758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.